These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 27114273)
1. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in U.S. Medical Centers, 2012 to 2014. Sader HS; Castanheira M; Flamm RK; Jones RN Antimicrob Agents Chemother; 2016 Jul; 60(7):4355-60. PubMed ID: 27114273 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015. Sader HS; Castanheira M; Flamm RK Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial activity of ceftazidime-avibactam against Gram-negative organisms collected from U.S. medical centers in 2012. Sader HS; Castanheira M; Flamm RK; Farrell DJ; Jones RN Antimicrob Agents Chemother; 2014; 58(3):1684-92. PubMed ID: 24379201 [TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016. Sader HS; Castanheira M; Shortridge D; Mendes RE; Flamm RK Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827415 [TBL] [Abstract][Full Text] [Related]
5. In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014). Nichols WW; de Jonge BL; Kazmierczak KM; Karlowsky JA; Sahm DF Antimicrob Agents Chemother; 2016 Aug; 60(8):4743-9. PubMed ID: 27216074 [TBL] [Abstract][Full Text] [Related]
6. Ceftazidime-Avibactam Antimicrobial Activity and Spectrum When Tested Against Gram-negative Organisms From Pediatric Patients: Results From the INFORM Surveillance Program (United States, 2011-2015). Sader HS; Huband MD; Duncan LR; Flamm RK Pediatr Infect Dis J; 2018 Jun; 37(6):549-554. PubMed ID: 29206750 [TBL] [Abstract][Full Text] [Related]
7. Pseudomonas aeruginosa Antimicrobial Susceptibility Results from Four Years (2012 to 2015) of the International Network for Optimal Resistance Monitoring Program in the United States. Sader HS; Huband MD; Castanheira M; Flamm RK Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28069652 [No Abstract] [Full Text] [Related]
8. In vitro activity of ceftazidime/avibactam against urinary isolates from patients in a Phase 3 clinical trial programme for the treatment of complicated urinary tract infections. Stone GG; Bradford PA; Yates K; Newell P J Antimicrob Chemother; 2017 May; 72(5):1396-1399. PubMed ID: 28088768 [TBL] [Abstract][Full Text] [Related]
9. Ceftazidime-Avibactam Activity against Aerobic Gram Negative Organisms Isolated from Intra-Abdominal Infections in United States Hospitals, 2012-2014. Sader HS; Castanheira M; Flamm RK; Huband MD; Jones RN Surg Infect (Larchmt); 2016 Aug; 17(4):473-8. PubMed ID: 27104633 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Clinical Bacteria Isolated from Patients with Cancer. Hachem R; Reitzel R; Rolston K; Chaftari AM; Raad I Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115350 [TBL] [Abstract][Full Text] [Related]
12. Ceftazidime-avibactam and comparator agents tested against urinary tract isolates from a global surveillance program (2011). Flamm RK; Sader HS; Farrell DJ; Jones RN Diagn Microbiol Infect Dis; 2014 Nov; 80(3):233-8. PubMed ID: 25128477 [TBL] [Abstract][Full Text] [Related]
13. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia. Sader HS; Castanheira M; Flamm RK; Mendes RE; Farrell DJ; Jones RN Int J Antimicrob Agents; 2015 Jul; 46(1):53-9. PubMed ID: 25956844 [TBL] [Abstract][Full Text] [Related]
14. Stone GG; Bradford PA; Tawadrous M; Taylor D; Cadatal MJ; Chen Z; Chow JW Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071051 [TBL] [Abstract][Full Text] [Related]
15. Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014). Sader HS; Castanheira M; Farrell DJ; Flamm RK; Jones RN Diagn Microbiol Infect Dis; 2015 Dec; 83(4):389-94. PubMed ID: 26162518 [TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ceftazidime/avibactam against Gram-negative pathogens isolated from pneumonia in hospitalised patients, including ventilated patients. Flamm RK; Nichols WW; Sader HS; Farrell DJ; Jones RN Int J Antimicrob Agents; 2016 Mar; 47(3):235-42. PubMed ID: 26920105 [TBL] [Abstract][Full Text] [Related]
17. In Vitro Activity of Ceftazidime-Avibactam against Isolates in a Phase 3 Open-Label Clinical Trial for Complicated Intra-Abdominal and Urinary Tract Infections Caused by Ceftazidime-Nonsusceptible Gram-Negative Pathogens. Stone GG; Bradford PA; Newell P; Wardman A Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872067 [TBL] [Abstract][Full Text] [Related]
18. Clinical activity of ceftazidime/avibactam against MDR Enterobacteriaceae and Pseudomonas aeruginosa: pooled data from the ceftazidime/avibactam Phase III clinical trial programme. Stone GG; Newell P; Gasink LB; Broadhurst H; Wardman A; Yates K; Chen Z; Song J; Chow JW J Antimicrob Chemother; 2018 Sep; 73(9):2519-2523. PubMed ID: 29912399 [TBL] [Abstract][Full Text] [Related]
19. Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012). Flamm RK; Farrell DJ; Sader HS; Jones RN J Antimicrob Chemother; 2014 Jun; 69(6):1589-98. PubMed ID: 24562613 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of ceftazidime-avibactam against Gram-negative isolates collected in 18 European countries, 2015-2017. Stone GG; Seifert H; Nord CE Int J Antimicrob Agents; 2020 Sep; 56(3):106045. PubMed ID: 32522673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]